Aclaris Therapeutics
ACRS
ACRS
128 hedge funds and large institutions have $1.04B invested in Aclaris Therapeutics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3.32% more ownership
Funds ownership: 95.35% → 98.67% (+3.3%)
1% more funds holding
Funds holding: 127 → 128 (+1)
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Holders
128
Holding in Top 10
6
Calls
$483K
Puts
$362K
Top Buyers
| 1 | +$32M | |
| 2 | +$4.38M | |
| 3 | +$3M | |
| 4 |
Walleye Capital
New York
|
+$2.35M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$2.11M |
Top Sellers
| 1 | -$11M | |
| 2 | -$8.35M | |
| 3 | -$6.26M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.87M |
| 5 |
ACM
Aisling Capital Management
New York
|
-$3.15M |